Inspire Medical Systems (NYSE:INSP) shares dipped today on third-quarter results that came in ahead of the consensus forecast ...

Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, ...

H.C. Wainwright analyst Edward White has reiterated their bullish stance on NYXH stock, giving a Buy rating on November 5. Edward White has ...

Year Revenue Growth of 33% and Earnings per Share of $0.60 in the Third QuarterMINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- , Inc. (NYSE: INSP) (Inspire, or the company), a medical technology ...

Nyxoah Appoints John Landry as Chief Financial Officer Current CFO, Loïc Moreau, to Transition into Role of President ...

Nyxoah’s financial report for the third quarter 2024, including details of the consolidated results, are available on the investor page of Nyxoah’s website (https://investors.nyxoah.com/financials).

Inspire Medical Systems topped Q3 expectations, signaling continued market strength and innovation.

minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR and PDMA-approved neurostimulation technology of ...

The global periodontal disease treatment market is projected to reach USD 3.63 billion by 2030 from USD 2.58 billion in 2024, growing at a CAGR of 5.9% during the forecast period 2024-2030. In all the ...

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary ...

The technology company has filed a patent for an innovative "smart pillow" aimed at treating obstructive sleep apnea (OSA). If snoring noises are detected, air chambers change the position of the ...